The increase in price target from $56 to $65 by Wedbush reflects a positive outlook on DocuSign's valuation, potentially leading to increased investor confidence and a short-term positive impact on the stock price. However, the maintenance of a Neutral rating suggests that while the outlook is improved, there may still be factors that could limit significant upside in the near term.